Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Merger agrmnt [a]
Quarterly results
CC transcript
Inv. presentation
Director departure
Appointed director
|
|
AMICUS THERAPEUTICS, INC. (FOLD)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/30/2015 |
8-K
| Amended merger/acquisition agreement|
Docs:
|
"Amendment to Agreement and Plan of Merger, by and among Amicus Therapeutics, Inc., Titan Merger Sub Corp., Scioderm, Inc., Fortis Advisors LLC, as Shareholders' Agent and certain Shareholders of Scioderm, Inc",
"Consent of Ernst & Young LLP, independent auditors of Scioderm, Inc",
"Amicus Therapeutics Completes Acquisition of Scioderm, Inc.",
"Presentation",
"Audited Consolidated Financial Statements and Related Notes of Scioderm, Inc. as of December 31, 2014 and December 31, 2013 and for the years then ended",
"Unaudited Consolidated Financial Statements and Related Notes of Scioderm, Inc. for the six-months ended June 30, 2015",
"Unaudited Pro Forma Condensed Combined Financial Information" |
|
|
|